AANP Adult Gerontology Primary Care Nurse Practitioner Practice Exam 2025 – The All-in-One Resource to Ensure Exam Success!

Albuterol, a short-acting beta-agonist, is commonly used for quick relief of asthma symptoms, while low-dose inhaled corticosteroids (ICS) are utilized for long-term control of inflammation. In the management of asthma, the combination of as-needed albuterol with a low dose of ICS is particularly appropriate in the context of mild persistent asthma.

Mild persistent asthma is characterized by symptoms occurring more than two days a week but not daily, and nighttime awakenings occurring 3-4 times a month. The use of albuterol on an as-needed basis allows for the management of occasional symptoms when they occur, while the low-dose ICS continually works to reduce airway inflammation, improving overall control of the condition.

As asthma severity increases, the management approach evolves, often requiring more consistent and intensive therapy such as higher doses of ICS or the addition of other medications. This dynamic justifies the use of albuterol in tandem with a low-dose ICS specifically for patients classified under mild persistent asthma, making this combination the most appropriate choice for that treatment step.